Retrospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jun 21, 2017; 23(23): 4270-4277
Published online Jun 21, 2017. doi: 10.3748/wjg.v23.i23.4270
Table 1 Patients’ demographic characteristics and diagnoses
RL-LDLT (n = 199)LL-LDLT (n = 19)P value
Median age (yr) (range)53 (17-72)52 (17-67)0.997
Male:Female165:348:110.000
Diagnosis
Liver cirrhosis
Cryptogenic31
Hepatitis B virus infection850
Hepatitis C virus infection155
Alcohol40
Infection of hepatitis B and C viruses20
Alcohol + hepatitis C virus infection30
Alcohol + hepatitis B virus infection10
Chronic active hepatitis B11
Fulminant hepatic failure
Cryptogenic11
Hepatitis B20
Autoimmune10
Drug-induced31
Biliary atresia20
Primary sclerosing cholangitis01
Primary biliary cirrhosis21
Graft failure40
Liver cirrhosis with acute deterioration
Cryptogenic20
Hepatitis B303
Alcohol10
Autoimmune10
Wilson's disease20
Chronic active hepatitis with acute flare
Hepatitis B321
Autoimmune10
Osler-Weber-Rendu syndrome10
Neuroendocrine syndrome01
Familial amyloid polyneuropathy01
Caroli disease01
Recurrent pyogenic cholangitis01
Hepatocellular carcinoma83 (41.7%)5 (26.3%)0.191
Table 2 Patients’ perioperative details
RL-LDLT (n = 199)LL-LDLT (n = 19)P value
Waiting time (d)11 (1-1354)16 (1-381)0.190
Preoperative MELD score20 (6-50)14 (6-40)0.184
GW (g)530 (320-715)410 (310-585)0.000
GW/RSLV (%)42.8 (28.4-46.998)36.3 (27.3-46.96)0.000
GW/RBW (%)0.77 (0.46-1.03)0.72 (0.49-1.04)0.236
Graft cold ischemic time (min)105 (53-243)85 (69-134)0.007
Recipient warm ischemic time (min)51 (25-89)45 (27-63)0.088
Splenic artery ligation00-
Portosystemic shunt00-
Ligation of shunt2 (1.0%)01.000
Blood transfusion (units)4 (0-39)2 (0-14)0.099
Fresh frozen plasma transfusion (units)9 (0-38)6 (0-23)0.145
Platelet transfusion (units)6 (0-32)3 (0-22)0.341
Operation time (min)685 (400-1203)670 (485-1273)0.738
Intensive care unit stay (d)4 (1-124)6 (2-16)0.055
Hospital stay (d)17 (2-128)23 (10-68)0.072
Follow-up period (d)86.9 (0.07-162.9)133.7 (0.53-159.2)0.054
Table 3 Survival outcomes and postoperative complications in recipients n (%)
RL-LDLT (n = 199)LL-LDLT (n = 19)P value
In-hospital death4 (2)1 (5.3)0.918
Graft loss33 (16.6)5 (26.3)0.452
Patient status - Alive:Dead169:3015:40.722
Graft survival0.049
1-yr98.50%89.50%
3-yr95.80%89.50%
5-yr95.20%89.50%
Patient survival0.476
1-yr95.90%89.50%
3-yr90.80%89.50%
5-yr86.80%89.50%
Postoperative complication10.105
No complication92 (46.2)7 (36.8)
Grade 142 (21.1)3 (15.8)
Grade 221 (10.6)0
Grade 3a19 (9.5)5 (26.3)
Grade 3b14 (7.0)3 (15.8)
Grade 4a7 (3.5)0
Grade 4b2 (1.0)0
Grade 52 (1.0)1 (5.3)
Reason for graft loss
Patient death283
Hepatic artery thrombosis10
Portal vein thrombosis10
PV/IVC thrombosis10
Recurrent Wilson's disease10
Biliary complication01
Reactivation of hepatitis C01
Rejection10
Cause of death
Acute myocardial infarction20
Chronic rejection10
Unknown20
Invasive aspergillosis10
Malignant cachexia160
Sepsis/multiorgan failure32
Subarachnoid hemorrhage10
Graft failure from PV/IVC thrombosis10
Lymphoproliferative disease10
Pulmonary hypertension10
Respiratory failure10
Chronic heart failure01
Reactivation of hepatitis C01
Table 4 Donor details
RL-LDLT (n = 199)LL-LDLT (n = 19)P value
Male:Female39:16016:30.000
Median age (yr) (range)34 (18-58)32 (18-55)0.847
Death1 (0.5%)01.000
Postoperative complication10.905
No complication16618
Grade 1141
Grade 280
Grade 3a40
Grade 3b50
Grade 4a10
Grade 4b00
Grade 510